News

Hemostemix Engages Montreal’s RobboDesign to SEO Its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally

Staff March 31, 2023

Calgary, Alberta--(Newsfile Corp. - March 29, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Staff March 31, 2023

New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic...

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

Staff March 31, 2023

Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023Signed License Agreement with Baylor BioSciences to...

ContraFect Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Provides Business Update

Staff March 31, 2023

YONKERS, N.Y., March 31, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...

SCYNEXIS Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Staff March 31, 2023

SCYNEXIS announced it has signed an exclusive agreement with GSK to commercialize and further develop BREXAFEMME® (ibrexafungerp tablets) for all...

Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress

Staff March 31, 2023

MALVERN, Pa., March 31, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...

Nexcella Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells

Staff March 31, 2023

LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”) today announced that an editorial...

Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

Staff March 31, 2023

~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss (Ototoxicity) in...

Samsung Bioepis Receives Positive CHMP Opinion for Eculizumab Biosimilar, EPYSQLI™

Staff March 31, 2023

EPYSQLI™, a biosimilar referencing Soliris1 (eculizumab), is Samsung Bioepis’ first biosimilar in hematology to be recommended for marketing authorization by...

Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Staff March 31, 2023

WALTHAM, Mass., March 31, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...

Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update

Staff March 31, 2023

$17.5 Million in Cash and Marketable Securities as of December 31, 2022; Expected to Support Operations Into Second Half of...

Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells

Staff March 31, 2023

LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”,...

Cidara Therapeutics to Participate in Upcoming Investor Conferences

Staff March 31, 2023

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...

Jasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium

Staff March 31, 2023

REDWOOD CITY, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on development...

TScan Therapeutics Announces CEO Transition

Staff March 31, 2023

David Southwell steps down; Gavin MacBeath, Ph.D., Chief Scientific and Operating Officer, to serve as acting CEO Company reaffirms previously...

STRATA Skin Sciences Reports Record Fourth Quarter 2022 Revenue

Staff March 31, 2023

Achieved record revenue of $36.2 million, representing 21% increase over the year 2021 Company to host conference call and webcast...

Reflect Scientific Inc Announces Year-End Financial Results for 2022

Staff March 31, 2023

OREM, Utah, March 31, 2023 (GLOBE NEWSWIRE) -- Reflect Scientific Inc (OTCQB: RSCF), a provider of ultra-low temperature freezers and...

Alimera Sciences Announces 2022 Financial Results and Business Update

Staff March 31, 2023

• 2022 Product Revenue Increased to $54.1 Million, Up 13% over 2021 • Global End User Demand Increased 22% over 2021...

Immutep Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023

Staff March 31, 2023

Media Release Efti plus pembrolizumab achieved mOS of 9.9 months and a 39% OS rate at 21 months, which compare...

NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update

Staff March 31, 2023

-- Completed business combination with FLAC and closed concurrent, oversubscribed approximately $235 million PIPE, led by Frazier Healthcare Partners and...

News

Hemostemix Engages Montreal’s RobboDesign to SEO Its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

ContraFect Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Provides Business Update

SCYNEXIS Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress

Nexcella Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells

Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

Samsung Bioepis Receives Positive CHMP Opinion for Eculizumab Biosimilar, EPYSQLI™

Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update

Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells

Cidara Therapeutics to Participate in Upcoming Investor Conferences

Jasper Therapeutics to Present at Cantor Fitzgerald’s The Future of Oncology Virtual Symposium

TScan Therapeutics Announces CEO Transition

STRATA Skin Sciences Reports Record Fourth Quarter 2022 Revenue

Reflect Scientific Inc Announces Year-End Financial Results for 2022

Alimera Sciences Announces 2022 Financial Results and Business Update

Immutep Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023

NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers

10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store®

TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year

NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER

You may have missed